Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis

Slow infusion of TNK is equally efficacious but more effective than SK in the management of mitral mechanical PVT. 75% to 77.5% of PVT patients completely recovered from TT and it should be the first line therapy where the immediate surgical options were remote.